Evaluating the Safety and Efficacy of Single-Dose Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load

This study is currently recruiting participants. (see Contacts and Locations)

Verified August 2016 by National Institute of Allergy and Infectious Diseases (NIAID)

Sponsor:

Information provided by (Responsible Party):

National Institute of Allergy and Infectious Diseases (NIAID)

ClinicalTrials.gov Identifier:

NCT01933594

First received: August 28, 2013

Last updated: August 22, 2016

Last verified: August 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2016 (Final data collection date for primary outcome measure)